PD-1 and IL-15 receptor drugs for Non-Small Cell Lung Cancer
2 tracked PD-1 and IL-15 receptor drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PD-1 and IL-15 receptor page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 preclinical / unstaged